This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Diurnal Group Past Earnings Performance
Past criteria checks 0/6
Key information
1.4%
Earnings growth rate
28.6%
EPS growth rate
| Biotechs Industry Growth | 11.5% |
| Revenue growth rate | 51.1% |
| Return on equity | -77.0% |
| Net Margin | -353.8% |
| Last Earnings Update | 30 Jun 2022 |
Recent past performance updates
Recent updates
Diurnal Group (LON:DNL) Will Have To Spend Its Cash Wisely
Aug 13
Shareholders May Not Be So Generous With Diurnal Group plc's (LON:DNL) CEO Compensation And Here's Why
Nov 13Companies Like Diurnal Group (LON:DNL) Can Afford To Invest In Growth
Feb 25What Can We Learn About Diurnal Group's (LON:DNL) CEO Compensation?
Feb 04Diurnal Group plc (LON:DNL): When Will It Breakeven?
Jan 14Diurnal Group (LON:DNL) Shareholders Have Enjoyed A 88% Share Price Gain
Dec 25Estimating The Fair Value Of Diurnal Group plc (LON:DNL)
Dec 02Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Diurnal Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 22 | 5 | -17 | 10 | 12 |
| 31 Mar 22 | 5 | -15 | 10 | 11 |
| 31 Dec 21 | 5 | -13 | 9 | 10 |
| 30 Sep 21 | 5 | -12 | 9 | 9 |
| 30 Jun 21 | 4 | -10 | 8 | 7 |
| 31 Mar 21 | 5 | -7 | 8 | 6 |
| 31 Dec 20 | 6 | -5 | 8 | 5 |
| 30 Sep 20 | 6 | -4 | 8 | 5 |
| 30 Jun 20 | 6 | -4 | 7 | 5 |
| 31 Mar 20 | 4 | -6 | 7 | 5 |
| 31 Dec 19 | 2 | -8 | 6 | 5 |
| 30 Sep 19 | 2 | -10 | 6 | 7 |
| 30 Jun 19 | 1 | -12 | 7 | 9 |
| 31 Mar 19 | 1 | -14 | 7 | 10 |
| 31 Dec 18 | 0 | -16 | 7 | 12 |
| 30 Sep 18 | 0 | -15 | 7 | 11 |
| 30 Jun 18 | 0 | -15 | 7 | 10 |
| 31 Mar 18 | 0 | -13 | 6 | 10 |
| 31 Dec 17 | 0 | -10 | 5 | 9 |
| 30 Sep 17 | 0 | -10 | 4 | 9 |
| 30 Jun 17 | 0 | -9 | 4 | 8 |
| 31 Mar 17 | 0 | -9 | 3 | 7 |
| 31 Dec 16 | 0 | -9 | 2 | 6 |
| 30 Sep 16 | 0 | -8 | 2 | 5 |
| 30 Jun 16 | 0 | -7 | 2 | 4 |
Quality Earnings: DNL is currently unprofitable.
Growing Profit Margin: DNL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DNL is unprofitable, but has reduced losses over the past 5 years at a rate of 1.4% per year.
Accelerating Growth: Unable to compare DNL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: DNL is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-15.5%).
Return on Equity
High ROE: DNL has a negative Return on Equity (-76.98%), as it is currently unprofitable.